CRP and post-transplant lymphoproliferative disease: In multivariable analysis an increased risk of PTLD was significantly associated with high-risk D+R−, EBV IgG serostatus at transplant and current EBV DNAemia, lower hemoglobin, and higher CRP levels (Table 4).